Mr. Derek Chang is the Head of Novartis Hong Kong. He has 20 years of experience in the healthcare industry across markets in the Mainland China, Taiwan, Hong Kong and Germany.
As a Board member, Mr. Chang is committed to further engaging with more member companies, as well as contributing his diversity of experiences to different task forces and working groups to support the mission of HKAPI: “Expedite access of innovative healthcare solutions to the people in Hong Kong and Macau with high ethical standards”.